CAR T-Cell Therapy in Hematological Malignancies

Chimeric antigen receptor (CAR) T-cells (CAR T-cells) are a promising therapeutic approach in treating hematological malignancies. CAR T-cells represent engineered autologous T-cells, expressing a synthetic CAR, targeting tumor-associated antigens (TAAs) independent of major histocompatibility compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslauer, Theresa, Greil, Richard, Zaborsky, Nadja, Geisberger, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396650/
https://www.ncbi.nlm.nih.gov/pubmed/34445701
http://dx.doi.org/10.3390/ijms22168996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396650/
https://www.ncbi.nlm.nih.gov/pubmed/34445701
http://dx.doi.org/10.3390/ijms22168996

Ejemplares similares